Labcorp developing options to prioritize COVID-19 testing for inpatient population in support of guidance from the White House coronavirus task force

LabCorp Developing Options to Prioritize COVID-19 Testing for Inpatient Population in Support of Guidance from the White House Coronavirus Task Force

Company also preparing to support faster point-of-care testing for COVID-19 in hospitals once available BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2020-- LabCorp (NYSE: LH), a leading global life services company that is deeply integrated in guiding patient care, today announced that it is

Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access

Differentiated approach may improve detection methods and inform vaccine discovery for COVID-19 Other industry leaders including LabCorp, through its Covance drug development business, Illumina, and Providence join forces to accelerate this critical effort SEATTLE and REDMOND, Wash.

LabCorp Sets Dedicated Hours to Serve the Non-COVID-19 Testing Needs for Elderly and Most Vulnerable People

LabCorp ‘Wait Where You’re Comfortable’ and Mobile Check-In Options Reinforce Social Distancing Protocols BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the

Media Statement: Labcorp announces ability to perform 20,000 tests per day, doubles its COVID-19 testing capacity in one week

Information from LabCorp about coronavirus disease 2019 (COVID-19)